Nimesulide,
a widely prescribed anti-inflammatory analgesic drug belongs to BCS
class II and exhibit low and variable oral bioavailability.
Nimesulide
(4-nitro-2-phenoxymethanesulfoanilide) may be a particular Cox-2
anti-inflammatory medication. This compund, a by-result of p-nitrophenyl
methane arrangement sulfa, is structurally a solitary non-steroidal
anti-inflammatorydrug. It has a place with particular COX-2inhibitors,
with an intense pain relieving movement.
its shown as second line treatment for acute pain, symptomatic treatment of excruciating degenerative joint ailment and first dysmenorrhoea.
its shown as second line treatment for acute pain, symptomatic treatment of excruciating degenerative joint ailment and first dysmenorrhoea.
Nimesulide tablet incorporates:
- Fast results
- Helpful and supportive
- No feature impacts
- Fast and quick effects
- Nimesulide has less gastrointestinal adverse effects than other NSAIDs
- It has superior benefit-risk ratio to other drugs with a comparable safety and tolerability to placebo.
- Its multifactorial mode of action gives it a unique and broad action on inflammatory.
- Nimesulide is also safe in sensitive asthmatic patients. It is reported to be beneficial in relieving the symptoms of rhinitis, rhinopharyngitis tubaritis and seceretory otitis media with concomitant antibiotic treatment.
- Nimesulide has potent analgesic, anti-inflammatory and antipyretic activities